Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning

Cytokine

Volumn 53, Issue 3, 2011, Pages 376-383

  Poloni, Antonella ^a   Sartini, Davide ^a   Emanuelli, Monica ^a   Trappolini, Silvia ^a   Mancini, Stefania ^a   Pozzi, Valentina ^a   Costantini, Benedetta ^a   Serrani, Federica ^a   Berardinelli, Eleonora ^a   Renzi, Elisabetta ^a   Olivieri, Attilio ^b   Leoni, Pietro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAN CARLO HOSPITAL   (Italy)

Author keywords

Allogeneic stem cell transplantation; Chronic GVHD; Cytokines; Gene expression; Real time PCR

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKINE; FLUDARABINE; GAMMA INTERFERON; MELPHALAN; PLATELET DERIVED GROWTH FACTOR B; THIOTEPA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 3; UNCLASSIFIED DRUG;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CELL POPULATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNOCOMPETENT CELL; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REDUCED INTENSITY CONDITIONING; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-GAMMA; LYMPHOTOXIN-BETA; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-SIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTORS; YOUNG ADULT;

EID: 79251616681     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.12.008     Document Type: Article

References (29)

1. Filipovich A.H., Weisdorf D., Pavletic S., Socie G., Wingard J.R., Lee S.J., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005 Dec, 11(12):945-956.
2. Shulman H.M., Sullivan K.M., Weiden P.L., McDonald G.B., Striker G.E., Sale G.E., et al. A longterm clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69(2):204-217.
3. Kondo M., Kojima S., Horibe K., Kato K., Matsuyama T. Risk factors for chronic graft versus host disease after allogeneic stem cell transplantation in children. Bone Marrow Transplant 2001, 27(7):727-730.
4. Kollman C., Howe C.W., Anasetti C., Antin J.H., Davies S.M., Filipovich A.H., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001, 98(7):2043-2051.
5. Cutler C., Giri S., Jeyapalan S., Paniagua D., Viswanathan A., Antin J.H. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001, 19(16):3685-3691.
6. Przepiorka D., Anderlini P., Saliba R., Cleary K., Mehra R., Khouri I., et al. Chronic graft versus- host disease after allogeneic blood stem cell transplantation. Blood 2001, 98(6):1695-1700.
7. Remberger M., Kumlien G., Aschan J., Barkholt L., Hentschke P., Ljungman P., et al. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002, 8(12):674-682.
8. Paczesny S., Levine J.E., Braun T.M., Ferrara J.L. Plasma biomarkers in graft-versus-host disease: a new era?. Biol Blood Marrow Transplant 2009, 15(1 Suppl.):33-38.
9. Schultz K.R., Miklos D.B., Fowler D., Cooke K., Shizuru J., Zorn E., et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 2006, 12(2):126-137.
10. Liem L.M., Fibbe W.E., van Houwelingen H.C., Goulmy E. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation 1999, 67(1):59-65.
11. Tanaka J., Imamura M., Kasai M., Hashino S., Kobayashi S., Noto S., et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease. Bone Marrow Transplant 1997, 19(6):571-576.
12. Lauwerys B.R., Renauld J.C., Houssiau F.A. Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs.-host disease: synergism with IL-18. Eur J Immunol 1998, 28(6):2017-2024.
13. Pérez-Simón J.A., Díez-Campelo M., Martino R., Brunet S., Urbano A., Caballero M.D., et al. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Br J Haematol 2005, 130(3):394-403.
14. Choi S.W., Levine J.E., Ferrara J.L. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am 2010 Feb, 30(1):75-101.
15. Clark F.J., Gregg R., Piper K., Dunnion D., Freeman L., Griffiths M., et al. Chronic graft versus host disease is associated with increased number of peripheral blood CD4+CD25 high regulatory T cells. Blood 2004, 103(6):2410-2416.
16. Nestel F.P., Price K.S., Seemayer T.A., Lapp W.S. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 1992, 175(2):405-413.
17. Fowler D.H., Foley J., Whit-Shan Hou J., Odom J., Castro K., Steinberg S.M., et al. Clinical " cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease. Clin Gastroenterol Hepatol 2004, 2(3):237-245.
18. Ratanatharathorn V., Pavletic S., Uberti J.P. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects. Cancer Treat Rev. 2009, 35(8):653-661. [Epub 2009 Aug 13. Review].
19. Kögler G., Middleton P.G., Wilke M., Rocha V., Esendam B., Enczmann J., et al. Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis. Transplantation 2002, 74(8):1167-1175.
20. Skert C., Damiani D., Michelutti A., Patriarca F., Arpinati M., Filì C., et al. Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. Bone Marrow Transplant 2009, 44(11):729-737.
21. Ellison C.A., Bradley D.S., Fischer J.M., Hayglass K.T., Gartner J.G. Murine graft-versus host disease induced using interferon-gamma-deficient grafts features antibodies to doublestranded DNA, T helper 2-type cytokines and hypereosinophilia. Immunology 2002 Jan, 105(1):63-72.
22. Cavet J., Dickinson A.M., Norden J., Taylor P.R., Jackson G.H., Middleton P.G. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001, 98(5):1594-1600.
23. Harlin H., Artz A.S., Mahowald M., Rini B.I., Zimmerman T., Vogelzang N.J., et al. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells. Bone Marrow Transplant 2004, 33(5):491-497.
24. Ritchie D., Seconi J., Wood C., Walton J., Watt V. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005, 11(9):706-712.
25. Ludwicka A., Ohba T., Trojanowska M., Yamakage A., Strange C., Smith E.A., et al. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol 1995, 22(10):1876-1883.
26. Tan E.M., Qin H., Kennedy S.H., Rouda S., Fox J.W., Moore J.H. Platelet-derived growth factors-AA and -BB regulate collagen and collagenase gene expression differentially in human fibroblasts. Biochem J 1995, 310(Pt 2):585-588.
27. Svegliati S., Olivieri A., Campelli N., Luchetti M., Poloni A., Trappolini S., et al. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 2007, 110(1):237-241.
28. Zhang C., Todorov I., Zhang Z., Liu Y., Kandeel F., Forman S., et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 2006, 107(7):2993-3001.
29. Olivieri A., Locatelli F., Zecca M., Sanna A., Cimminiello M., Raimondi R., et al. Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 2009, 114(3):709-718.